Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

DUAVEE

BAZEDOXIFENE ACETATE; ESTROGENS, CONJUGATED

Standard Dose
EQ 20MG BASE;0.45MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview DUAVEE is listed in Drugs@FDA under application 022247 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient BAZEDOXIFENE ACETATE; ESTROGENS, CONJUGATED Form and strength TABLET;ORAL - EQ 20MG BASE;0.45MG Sponsor WYETH PHARMS Submission history Latest submission status date: 2024-03-04 00:00:00.

Structured Monograph

Clinical summary

Approval overview DUAVEE is listed in Drugs@FDA under application 022247 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient BAZEDOXIFENE ACETATE; ESTROGENS, CONJUGATED Form and strength TABLET;ORAL - EQ 20MG BASE;0.45MG Sponsor WYETH PHARMS Submission history Latest submission status date: 2024-03-04 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.